Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Cerilliant
McKesson
Express Scripts
Fish and Richardson
Chubb
Citi
Accenture
Healthtrust

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,817,338

« Back to Dashboard

Summary for Patent: 5,817,338
Title: Multiple unit tableted dosage form of omeprazole
Abstract:A new pharmaceutical multiple unit tableted dosage form containing omeprazole or one of its single enantiomers or an alkaline salt of omeprazole or one of its single enantiomers, a method for the manufacture of such a formulation, and the use of such a formulation in medicine.
Inventor(s): Bergstrand; Pontus John Arvid (Goteborg, SE), Lovgren; Kurt Ingmar (Molndal, SE)
Assignee: Astra Aktiebolag (Sodertalje, SE)
Application Number:08/454,395
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form; Compound; Process;

Drugs Protected by US Patent 5,817,338

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,817,338

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden9402432Jul 08, 1994
Sweden9402433Jul 08, 1994
PCT Information
PCT FiledJune 07, 1995PCT Application Number:PCT/SE95/00677
PCT Publication Date:January 25, 1996PCT Publication Number: WO96/01623

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Department of Justice
Farmers Insurance
UBS
McKesson
Cipla
Argus Health
US Army
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.